144 related articles for article (PubMed ID: 30127879)
1. Tumor targeting with docosahexaenoic acid-conjugated docetaxel for inhibiting lung cancer metastasis to bone.
Jiang S; Liu Z; Wu L; Yuan Y; Hu Y; Zhang X; Wei L; Zu Y
Oncol Lett; 2018 Sep; 16(3):2911-2920. PubMed ID: 30127879
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone.
Zu Y; Hu Y; Yu X; Jiang S
Anticancer Agents Med Chem; 2017; 17(4):542-551. PubMed ID: 27539313
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of docetaxel and gambogic acid on bone metastasis of lung cancer.
Zhang S; Zhang X; Zhang D; Wei L; Xiong B; Meng Q; Jiang S
Bull Cancer; 2023 May; 110(5):478-486. PubMed ID: 36890055
[TBL] [Abstract][Full Text] [Related]
4. Polysaccharide dextran-based conjugate for selective co-delivery of two synergistic drugs docetaxel and docosahexaenoic acid to tumor cells.
Dong P; Lv H; Jia W; Liu J; Wang S; Li X; Hu J; Zhao L; Shi Y
Drug Deliv; 2023 Dec; 30(1):40-50. PubMed ID: 36458324
[TBL] [Abstract][Full Text] [Related]
5. Osteoclasts and tumor cells dual targeting nanoparticle to treat bone metastases of lung cancer.
Bai SB; Liu DZ; Cheng Y; Cui H; Liu M; Cui MX; Zhang BL; Mei QB; Zhou SY
Nanomedicine; 2019 Oct; 21():102054. PubMed ID: 31310809
[TBL] [Abstract][Full Text] [Related]
6. Self-assembly of CXCR4 antagonist peptide-docetaxel conjugates for breast tumor multi-organ metastasis inhibition.
Li C; Lang J; Wang Y; Cheng Z; Zu M; Li F; Sun J; Deng Y; Ji T; Nie G; Zhao Y
Acta Pharm Sin B; 2023 Sep; 13(9):3849-3861. PubMed ID: 37719382
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor effect on intrapulmonary tumors of docetaxel lung-targeted liposomes in a rabbit model of VX2 orthotopic lung cancer.
Wang L; Li R; Che K; Liu Z; Xiang S; Li M; Yu Y
Sci Rep; 2017 Aug; 7(1):10069. PubMed ID: 28855665
[TBL] [Abstract][Full Text] [Related]
8. Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer.
Yang Q; Liu DZ; Liu M; Ji QF; Mei QB; Cheng Y; Zhou SY
J Pharm Sci; 2021 Feb; 110(2):876-887. PubMed ID: 33166581
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of docetaxel-loaded nanomicelles and their anti-Lewis lung cancer effect in vitro].
Wang YJ; Wang J; Hao DL; Yue QX; Xie R; DE GJ; Yi H; Zang C; Zhao QH; Chen YJ
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2251-2259. PubMed ID: 31359650
[TBL] [Abstract][Full Text] [Related]
10. Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo.
Pang X; Wang T; Jiang D; Mu W; Zhang B; Zhang N
Int J Nanomedicine; 2019; 14():2543-2555. PubMed ID: 31114190
[No Abstract] [Full Text] [Related]
11. Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer.
Liang Z; Yang N; Jiang Y; Hou C; Zheng J; Shi J; Zhang R; Li D; Liu Y; Zuo P
Int J Pharm; 2015 Oct; 494(1):337-45. PubMed ID: 26299762
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo.
Liu P; Chen L; Huang X
Cancer Biother Radiopharm; 2009 Feb; 24(1):91-8. PubMed ID: 19243251
[TBL] [Abstract][Full Text] [Related]
13. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
[TBL] [Abstract][Full Text] [Related]
14. Bone-targeted PAMAM nanoparticle to treat bone metastases of lung cancer.
Bai SB; Cheng Y; Liu DZ; Ji QF; Liu M; Zhang BL; Mei QB; Zhou SY
Nanomedicine (Lond); 2020 Apr; 15(9):833-849. PubMed ID: 32163008
[No Abstract] [Full Text] [Related]
15. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation.
Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y
Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488
[TBL] [Abstract][Full Text] [Related]
16. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
17. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity.
Wang J; Xue P; Zhou J; Li L; Xu L; Wang Y
Int J Pharm; 2016 May; 505(1-2):352-60. PubMed ID: 27085643
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption
Kishikawa A; Kitaura H; Kimura K; Ogawa S; Qi J; Shen WR; Ohori F; Noguchi T; Marahleh A; Nara Y; Ichimura A; Mizoguchi I
Front Endocrinol (Lausanne); 2019; 10():157. PubMed ID: 30949128
[TBL] [Abstract][Full Text] [Related]
20. Effect of combination therapy with a novel bisphosphonate, minodronate (YM529), and docetaxel on a model of bone metastasis by human transitional cell carcinoma.
Inoue K; Karashima T; Fukata S; Nomura A; Kawada C; Kurabayashi A; Furihata M; Ohtsuki Y; Shuin T
Clin Cancer Res; 2005 Sep; 11(18):6669-77. PubMed ID: 16166446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
